| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hyponatremia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Inappropriate ADH Syndrome | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Disease | |||||
| Endocrine System Diseases | |||||
| Hypothalamic Diseases | |||||
| Metabolic Diseases | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| Pituitary Diseases | |||||
| Water-Electrolyte Imbalance | |||||
| 4 | Interventions listed in this trial | ||||
| satavaptan (SR121463B) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Arginine Vasopressin | |||||
| Vasopressins | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antidiuretic Agents | |||||
| Cardiovascular Agents | |||||
| Coagulants | |||||
| Hematologic Agents | |||||
| Hemostatics | |||||
| Natriuretic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasoconstrictor Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| Sanofi-Aventis | |||||
|
